InfoBionic.Ai

InfoBionic.Ai is a Boston-based private company, founded in 2015, that has developed a sophisticated AI-enabled remote cardiac monitoring platform called MoMe ARC®. The system combines interchangeable biosensors, advanced AI analytics, and a seamless IT infrastructure to support virtual cardiac telemetry for a wide range of patient acuity levels. Recognized as a gold standard in the field, the company targets cardiology practices, hospitals, and health systems seeking to improve the efficiency and quality of their remote monitoring services. Its recent FDA clearance for a patch-based sensor marks a significant step in its product evolution.

The MoMe ARC® platform is an AI-enabled remote cardiac monitoring system featuring interchangeable pod-based biosensors (including a patch), AI-driven ECG analysis for arrhythmia detection, and a business intelligence analytics suite. It is designed for hospital-grade, continuous monitoring with seamless IT integration and real-time data transmission.

InfoBionic.Ai competes in the remote cardiac monitoring market against established medical device companies (e.g., Medtronic, Abbott, iRhythm), other digital health startups, and large technology firms entering healthcare. It differentiates itself through its interchangeable sensor system, claim of 100% data transmission, and a strong focus on AI-driven clinical workflow enhancement for enterprise health systems.